Los Angeles Capital Management
ANAB icon

Los Angeles Capital Management’s AnaptysBio ANAB Stock Holding History

Los Angeles Capital Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
17,536
+1,872
+12% +$113K ﹤0.01% 703
2026
Q1 		$869K Buy
15,664
+563
+4% +$30.3K ﹤0.01% 716
2025
Q4 		$551K Buy
15,101
+225
+2% +$8.77K ﹤0.01% 852
2025
Q3 		$456K Sell
14,876
-151
-1% -$3.46K ﹤0.01% 965
2025
Q2 		$334K Buy
+15,027
New +$315K ﹤0.01% 1009
2022
Q3 		– Sell
-20,783
Closed -$422K – 1218
2022
Q2 		$422K Sell
20,783
-84,828
-80% -$1.88M ﹤0.01% 1027
2022
Q1 		$2.61M Sell
105,611
-16,285
-13% -$493K 0.01% 472
2021
Q4 		$4.24M Sell
121,896
-8,664
-7% -$275K 0.02% 374
2021
Q3 		$3.54M Buy
130,560
+4,355
+3% +$111K 0.02% 400
2021
Q2 		$3.27M Buy
126,205
+50,175
+66% +$1.2M 0.01% 466
2021
Q1 		$1.64M Buy
76,030
+65,660
+633% +$1.66M 0.01% 685
2020
Q4 		$223K Sell
10,370
-11,650
-53% -$283K ﹤0.01% 1451
2020
Q3 		$325K Buy
22,020
+2,300
+12% +$41.5K ﹤0.01% 1243
2020
Q2 		$441K Buy
19,720
+8,170
+71% +$149K ﹤0.01% 1160
2020
Q1 		$163K Buy
+11,550
New +$175K ﹤0.01% 1225
2019
Q4 		– Sell
-12,470
Closed -$436K – 1264
2019
Q3 		$436K Hold
12,470
– – ﹤0.01% 1023
2019
Q2 		$704K Buy
12,470
+1,635
+15% +$118K ﹤0.01% 951
2019
Q1 		$791K Buy
10,835
+860
+9% +$59.4K ﹤0.01% 936
2018
Q4 		$636K Sell
9,975
-1,985
-17% -$148K ﹤0.01% 890
2018
Q3 		$1.19M Sell
11,960
-11,330
-49% -$940K 0.01% 808
2018
Q2 		$1.66M Buy
+23,290
New +$1.95M 0.01% 747

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Los Angeles Capital Management's ANAB Position: Q2 2026 in Review

Los Angeles Capital Management increased its AnaptysBio (ANAB) stake by 12% in Q2 2026, buying an estimated $113K and bringing the position to 17,536 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #703.

Los Angeles Capital Management first reported a position in ANAB in Q2 2018 and has held it in 21 quarters since. The position peaked at $4.24M in Q4 2021. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Los Angeles Capital Management held 17,536 shares of AnaptysBio worth $1.18M as of Q2 2026.
  • Los Angeles Capital Management bought 1,872 AnaptysBio shares in Q2 2026, an estimated $113K.
  • AnaptysBio made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #703 holding.
  • Los Angeles Capital Management first reported a position in AnaptysBio in Q2 2018 and has held it in 21 quarters since.
  • Los Angeles Capital Management's AnaptysBio position peaked at $4.24M in Q4 2021.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.